Upgrade to SI Premium - Free Trial

Merck (MRK) PT Raised to $172 at HSBC

September 10, 2026 3:28 AM
HSBC analyst Rajesh Kumar raised the price target on Merck (NYSE: MRK) to $172.00 (from $150.00) while maintaining a Buy rating.

Categories

Analyst PT Change